Intrinsic Value of S&P & Nasdaq Contact Us

Geron Corporation GERN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
55/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.89
+248.5%

Geron Corporation (GERN) has 20 known insider and institutional holders on record. The largest holder is Semerjian Harout with 4,000,000 shares. Other notable holders include Eid Joseph and ROBERTSON MICHELLE.

Over the last 12 months, insiders have made 23 transactions in GERN stock — 18 buys (valued at $18.58M) and 1 sells (valued at $19.12K). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

GERN Insider Ownership

Top Holder
Semerjian Harout
4,000,000 shares
Buys (12 mo)
18
$18.58M value
Sells (12 mo)
1
$19.12K value
12-Month Transaction Activity
Buy 78%
Sell 4%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Semerjian Harout President and CEO 4,000,000 2025-08-08
100%
2 Eid Joseph EVP, R&d; Chief Medical Office 2,220,000 2026-02-19
56%
3 Robertson Michelle EVP, Chief Financial Officer 1,660,000 2026-02-19
42%
4 Rizo Aleksandra EVP, Chief Medical Officer 750,000 2022-02-18
19%
5 Rosenfield Stephen EVP, Chief Legal Off & Sec 750,000 2022-02-18
19%
6 Okarma Thomas President and CEO 504,560 2010-07-13
13%
7 Earp David SVP, Corp Transactions 467,406 2012-06-01
12%
8 Parker Craig C EVP, Corp Dev & Sci Affairs 400,000 2014-02-12
10%
9 Barkas Alexander E Director 348,122 2011-05-24
9%
10 Behrs Melissa Kelly EVP, Chief Business Officer 300,000 2021-02-04
8%
11 Andrews Patricia S Director 270,000 2026-03-26
7%
12 Chinoporos Constantine Director 270,000 2026-03-26
7%
13 Kapur Anil EVP, Corp Strategy & Cco 250,000 2024-06-07
6%
14 Bloom Olivia Kyusuk EVP, Chief Financial Officer 250,000 2023-09-21
6%
15 Kelly Melissa VP, Oncology 246,096 2005-08-01
6%
16 Cooper Graham K EVP, Bus Dev & CFO 200,000 2012-05-18
5%
17 Spiegel Robert J. Director 199,707 2026-04-01
5%
18 Fritzky Edward V Director 186,511 2013-05-24
5%
19 Molineaux Susan Director 180,000 2025-05-22
5%
20 Lawlis V Bryan Director 180,000 2025-05-22
5%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-03-31 Spiegel Robert J. Director RSU Award 5,243 $1.49 $7.81K
2026-03-25 Chinoporos Constantine Director RSU Award 270,000 $1.57 $423.9K
2026-03-25 Chinoporos Constantine Officer Unknown - - -
2026-03-25 Andrews Patricia S Director RSU Award 270,000 $1.57 $423.9K
2026-03-25 Andrews Patricia S Officer Unknown - - -
2026-02-17 Eid Joseph EVP, R&d; Chief Medical Office RSU Award 2,220,000 $1.80 $4M
2026-02-18 Robertson Michelle EVP, Chief Financial Officer Informative Sell 9,855 $1.94 $19.12K
2026-02-17 Robertson Michelle EVP, Chief Financial Officer RSU Award 1,660,000 $1.80 $2.99M
2025-12-31 Spiegel Robert J. Director RSU Award 5,918 $1.32 $7.81K
2025-10-20 Elnawawi Ahmed EVP, Chief Commercial Officer RSU Award 3,000,000 $1.27 $3.81M
2025-10-20 Elnawawi Ahmed EVP, Chief Commercial Officer Unknown - - -
2025-09-30 Spiegel Robert J. Director RSU Award 5,702 $1.37 $7.81K
2025-08-07 Semerjian Harout President and CEO RSU Award 4,000,000 $1.30 $5.2M
2025-08-07 Semerjian Harout President and CEO Unknown - - -
2025-06-30 Spiegel Robert J. Director RSU Award 5,540 $1.41 $7.81K
2025-05-21 Mcdonald John F Director RSU Award 180,000 $1.34 $241.2K
2025-05-21 O'farrell Elizabeth G. Director RSU Award 180,000 $1.34 $241.2K
2025-05-21 Bir Dawn Carter Interim President and CEO RSU Award 180,000 $1.34 $241.2K
2025-05-21 Molineaux Susan Director RSU Award 180,000 $1.34 $241.2K
2025-05-21 Aggarwal Gaurav Director RSU Award 180,000 $1.34 $241.2K
2025-05-21 Spiegel Robert J. Director RSU Award 180,000 $1.34 $241.2K
2025-05-21 Lawlis V Bryan Director RSU Award 180,000 $1.34 $241.2K
2025-05-09 Lawlis V Bryan Director Informative Buy 13,300 $1.18 $15.67K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message